Olga P Plyushch - Concepedia

Author

Olga P Plyushch

National Medical Research Center for Hematology

Also Known As

O. P. Plyushch, O. PLYUSHCH, O. Plyushch, Olga P Plyushch, Olga P. Plyushch, Olga Plyushch, Tatyana A. Andreeva

Publications

332

Citations

H-Index

Concepts

All Affiliations

National Medical Research Center for Hematology Russian Academy of Sciences

About

Olga P Plyushch is an author at National Medical Research Center for Hematology specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	179
2	Cell Biology	2	2	106
3	Health Sciences	1	1	23
4	Public Health	1	1	17
5	Biomedical Engineering	1	1	33

Olga P Plyushch

Publications

295

Citations

H-Index

Page 1

	Year	Citations
Hemophilia A and B are associated with abnormal spatial dynamics of clot growth Mikhail V. Ovanesov, Julya V Krasotkina, Ljudmila I Ul'yanova, Biochimica et Biophysica Acta (BBA) - General Subjects GranulocytePathogenesisHematologyAbnormal Spatial DynamicsPathology	2002	74
Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes Jack Spira, Olga P Plyushch, Tatyana A. Andreeva, Blood	2006	60
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin, Haemophilia	2015	56
Effect of factor VIII on tissue factor-initiated spatial clot growth Mikhail V. Ovanesov, Elena Lopatina, Natalya M. Ananyeva, Thrombosis and Haemostasis InflammationThrombosisHematologyImmunologyPathology	2003	33
Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution Mikhail V. Ovanesov, Mikhail A. Panteleev, Elena I. Sinauridze, Blood Coagulation & Fibrinolysis Supraphysiological ConcentrationsTissue Factor ConcentrationImmunologyFactor ViiPlasma Lipid Particles	2008	32
Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study Jack Spira, Olga P Plyushch, N. I. Zozulya, Haemophilia ImmunohematologyPharmacotherapyFactor ViiaThrombosisOpen Label	2010	23
Long‐standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age‐matched Danish and Russian patients J. Ingerslev, Stefan Lethagen, Lone Hvitfeldt Poulsen, Haemophilia Logistic AnalysisPreventive MedicineHematologyClinical EpidemiologyFactor Viii	2013	17

Page 1